Hemizygous: To mimic hepatitis C infection in humans, Tg(tetO-HCV)1Mlch hemizygotes are bred to mice expressing the Cebpb-tTA (LaptTA) transgene and maintained on doxycycline through weaning to replicate the timing of hepatitis C infection in humans. Following withdrawal of doxycycline (dox), 50 to 60% of hepatocytes express the HCV core; expression is localized to the cytoplasmic vesicle membrane. HCV-positive hepatocytes are distributed randomly within the liver lobules. Expression is not detected in any of the other tissues tested. Mice do not exhibit significant hepatic inflammation although aminotransferase levels are elevated at one month after dox withdrawal. Hepatic steatosis is observed at two months of age; initially appearing as prominent microvesicular steatosis the pattern evolves to low-level macrovesicular steatosis paralleling the reduction in HCV-core expressing hepatocytes that occurs over time. This mutant mouse strain may be useful in studies of hepatic steatosis and hepatitis C infection.
Limited quantities of breeder mice (recovered litter) are available from a cryoarchive; recovered litter usually available to ship in 3 to 4 months.
TET-System Technology (tetracycline; US 5,814,618; 5,859,310; 7,541,446; 8,383,364 and European Patent EP 0804565)
The donor or their institution limits the distribution to non-profit institutions only.
Distribution of this strain requires submission of the MMRRC Conditions of Use (COU). A link to the COU web form will be provided via email after an order has been placed; the form should be completed then or the email forwarded to your institutional official for completion.
Additional charges may apply for any special requests. Shipping costs are in addition to the basic distribution/resuscitation fees. Information on shipping costs and any additional charges will be provided by the supplying MMRRC facility.
|MMRRC Item #||Description||Distribution Fee / Unit (US $)||Units||Notes|
|036053-JAX-RESUS||Litter recovered from cryo-archive||$2,022.00 / Non-Profit||Litter||Recovered litter1; additional fees for any special requests.|
1 The distribution fee covers the expense of resuscitating mice from the cryo-archive; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.
2 An aliquot is one straw or vial with sufficient sperm to recover at least one litter of mice, as per provided protocols, when performed at the MMRRC facility. The MMRRC makes no guarantee concerning the success of these procedures when performed outside the MMRRC facilities.
3 An aliquot contains a sufficient number of embryos (in one or more vials and based on the transfer success rate of the MMRRC facility) to transfer to at least two recipients. The MMRRC makes no guarantee concerning embryo transfer success experienced in the recipient investigator's laboratory. Neither gender nor genotype ratios are guaranteed.